← Human Trials & Peer-Reviewed Studies

L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study

Plain-language guide to PMID 17693145 (2007): double-blind randomized controlled trial study of L-Carnitine, celiac disease and gluten sensitivity.

Key Facts

PMID
17693145
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Year
2007
Study type
Randomized Controlled Trial
Authors
Ciacci C et al. (11 authors)
DOI
10.1016/j.dld.2007.06.013

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of L-Carnitine in the context of celiac disease and gluten sensitivity, published as a randomized controlled trial.

To evaluate the effect of L-carnitine treatment in fatigue in adult celiac patients.

Why It Was Studied

Fatigue is common in celiac disease.

L-Carnitine blood levels are low in untreated celiac disease.

Who Took Part

By PubMed's age tags, the people studied were adults, both men and women.

The patients underwent clinical investigation and questionnaires (Scott-Huskisson Visual Analogue Scale for Asthenia, Verbal Scale for Asthenia, Zung Depression Scale, SF-36 Health Status Survey, EuroQoL).

How the Study Was Run

The design is described as randomized, double-blind, placebo-controlled, parallel-group and pilot.

Random assignment meant chance, not the researchers, decided who got L-Carnitine and who got the comparison, which limits bias.

Blinding on both sides kept the participants and researchers unaware of who received L-Carnitine.

Some participants received a placebo instead of L-Carnitine, giving a reference point.

Groups ran in parallel: each of the participants stayed in one arm throughout.

Randomised double-blind versus placebo parallel study.

OCTN2 levels, the specific carnitine transporter, were detected in intestinal tissue.

What Was Measured

L-Carnitine blood levels are low in untreated celiac disease.

PubMed files the paper under topics including Biomarkers, Biopsy, Carnitine, Celiac Disease, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel and Fatigue.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of L-Carnitine in people with celiac disease and gluten sensitivity.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2007 (Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver), a journal based in Netherlands.

More context: the L-Carnitine compound page, Celiac disease and gluten sensitivity research.

Our Notes on the Compound

L-Carnitine: An amino acid derivative that carries fatty acids into mitochondria for energy production.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.